Home > Insider Trading > Filing (0000899243-19-027220)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1785173	89Bio Inc.	ETNB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1352908	R Michael Hayden	C/O 89Bio, Inc. 535 Mission Street, 14Th Floor San Francisco CA 94105		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-11	18,750	$16.00	18,750	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-11-13	58,978	$0.00	77,728	No	4	C	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	C	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-11-13	366,667	$0.00	58,978	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

On November 11, 2019, Genworks 2 Consulting Inc. purchased 18,750 shares of the Issuer's common stock at a price of $16.00 per share in the Issuer's initial public offering.
The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date.
These shares are held directly by Genworks 2 Consulting Inc., over which the Reporting Person's wife has sole voting and investment power.